These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 34501703)

  • 21. Community cervical cancer screening: Barriers to successful home-based HPV self-sampling in Dabat district, North Gondar, Ethiopia. A qualitative study.
    Megersa BS; Bussmann H; Bärnighausen T; Muche AA; Alemu K; Deckert A
    PLoS One; 2020; 15(12):e0243036. PubMed ID: 33306681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using self-collection HPV testing to increase engagement in cervical cancer screening programs in rural Guatemala: a longitudinal analysis.
    Gottschlich A; Rivera-Andrade A; Bevilacqua K; Murchland AR; Isak E; Alvarez CS; Ogilvie G; Carey TE; Prince M; Dean M; Mendoza-Montano C; Meza R
    BMC Public Health; 2020 Sep; 20(1):1406. PubMed ID: 32933512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Given a choice between self-sampling at home for HPV testing and standard of care screening at the clinic, what do African American women choose? Findings from a group randomized controlled trial.
    Scarinci IC; Li Y; Tucker L; Campos NG; Kim JJ; Peral S; Castle PE
    Prev Med; 2021 Jan; 142():106358. PubMed ID: 33338505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A conjoint analysis study on self-sampling for human papillomavirus (HPV) testing characteristics among black women in Indiana.
    Biederman E; Champion V; Zimet G
    BMC Womens Health; 2020 Mar; 20(1):55. PubMed ID: 32192493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acceptability of Self-Sampling for Human Papillomavirus-Based Cervical Cancer Screening.
    Chatzistamatiou K; Vrekoussis T; Tsertanidou A; Moysiadis T; Mouchtaropoulou E; Pasentsis K; Kitsou A; Moschaki V; Ntoula M; Zempili P; Halatsi D; Truva T; Piha V; Agelena G; Daponte A; Vanakara P; Paschopoulos M; Stefos T; Lymberis V; Kontomanolis EN; Makrigiannakis A; Deligeoroglou E; Panoskaltsis T; Adonakis G; Michail G; Stamatopoulos K; Agorastos T
    J Womens Health (Larchmt); 2020 Nov; 29(11):1447-1456. PubMed ID: 32757997
    [No Abstract]   [Full Text] [Related]  

  • 26. Acceptability and Feasibility of Human Papilloma Virus Self-Sampling for Cervical Cancer Screening.
    Ilangovan K; Kobetz E; Koru-Sengul T; Marcus EN; Rodriguez B; Alonzo Y; Carrasquillo O
    J Womens Health (Larchmt); 2016 Sep; 25(9):944-51. PubMed ID: 26890012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human Papilloma Virus self-sampling performance in low- and middle-income countries.
    Kamath Mulki A; Withers M
    BMC Womens Health; 2021 Jan; 21(1):12. PubMed ID: 33407355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized, controlled trial of two strategies of offering the home-based HPV self-sampling test to non- participants in the Flemish cervical cancer screening program.
    Kellen E; Benoy I; Vanden Broeck D; Martens P; Bogers JP; Haelens A; Van Limbergen E
    Int J Cancer; 2018 Aug; 143(4):861-868. PubMed ID: 29569715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of an educational intervention on women's knowledge and acceptability of human papillomavirus self-sampling: a randomized controlled trial in Cameroon.
    Sossauer G; Zbinden M; Tebeu PM; Fosso GK; Untiet S; Vassilakos P; Petignat P
    PLoS One; 2014; 9(10):e109788. PubMed ID: 25333793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HPV self-sampling and follow-up over two rounds of cervical screening in Australia - the iPap trial.
    Sultana F; Gertig DM; English DR; Simpson JA; Drennan KT; Wrede CD; Mullins RM; Heley S; Saville M; Brotherton JM
    J Med Screen; 2022 Sep; 29(3):185-193. PubMed ID: 35313763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acceptability of self-collected versus provider-collected sampling for HPV DNA testing among women in rural El Salvador.
    Rosenbaum AJ; Gage JC; Alfaro KM; Ditzian LR; Maza M; Scarinci IC; Felix JC; Castle PE; Villalta S; Miranda E; Cremer ML
    Int J Gynaecol Obstet; 2014 Aug; 126(2):156-60. PubMed ID: 24880188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging role of HPV self-sampling in cervical cancer screening for hard-to-reach women: Focused literature review.
    Madzima TR; Vahabi M; Lofters A
    Can Fam Physician; 2017 Aug; 63(8):597-601. PubMed ID: 28807952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the self-sampling for cervical cancer screening in Bolivia.
    Allende G; Surriabre P; Cáceres L; Bellot D; Ovando N; Torrico A; Calle P; Ascarrunz C; Alexander S; Bossens M; Fontaine V; Rodríguez P
    BMC Public Health; 2019 Jan; 19(1):80. PubMed ID: 30654774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinician acceptability of self-collected human papillomavirus swabs as a primary cervical cancer screening method.
    Zelli J; Hum S; Lofters A; Dunn S
    Can Fam Physician; 2022 Feb; 68(2):e31-e38. PubMed ID: 35177513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Barriers and Facilitators to Cervical Cancer Screening Among Women in Rural Ontario, Canada: The Role of Self-Collected HPV Testing.
    Racey CS; Gesink DC
    J Rural Health; 2016; 32(2):136-45. PubMed ID: 26265118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Barriers to HPV self-sampling and cytology among low-income indigenous women in rural areas of a middle-income setting: a qualitative study.
    Allen-Leigh B; Uribe-Zúñiga P; León-Maldonado L; Brown BJ; Lörincz A; Salmeron J; Lazcano-Ponce E
    BMC Cancer; 2017 Nov; 17(1):734. PubMed ID: 29121873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness and feasibility of self-sampling for human papillomavirus testing for internet-based cervical cancer screening.
    Li J; Wu R; Qu X; Huang X; Li L; Lin Z; Zhang Z; Deng J; Liu R; Zhao X; Zhang S; Lin B; An R; Zhao C; Li M; Zhao Y; Wei L
    Front Public Health; 2022; 10():938272. PubMed ID: 36420004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mailed HPV self-sampling for cervical cancer screening among underserved minority women: study protocol for a randomized controlled trial.
    Kobetz E; Seay J; Amofah A; Pierre L; Bispo JB; Trevil D; Gonzalez M; Poitevien M; Koru-Sengul T; Carrasquillo O
    Trials; 2017 Jan; 18(1):19. PubMed ID: 28086983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are we ready for human papillomavirus testing? Assessment of patient knowledge of and preferences for cervical cancer screening in Ontario.
    Elangainesan P; Naimer MS; Kukan S; Selk A
    Can Fam Physician; 2024; 70(7-8):479-490. PubMed ID: 39122425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cervical Cancer Screening Preferences Among Trans-Masculine Individuals: Patient-Collected Human Papillomavirus Vaginal Swabs Versus Provider-Administered Pap Tests.
    McDowell M; Pardee DJ; Peitzmeier S; Reisner SL; Agénor M; Alizaga N; Bernstein I; Potter J
    LGBT Health; 2017 Aug; 4(4):252-259. PubMed ID: 28665783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.